Clinical pharmacology, toxicity, and abuse potential of opioids

D Vearrier, O Grundmann - The Journal of Clinical …, 2021 - Wiley Online Library
Opioids were the most common drug class resulting in overdose deaths in the United States
in 2019. Widespread clinical use of prescription opioids for moderate to severe pain …

Oxycodone: a current perspective on its pharmacology, abuse, and pharmacotherapeutic developments

JE Barrett, A Shekarabi, S Inan - Pharmacological reviews, 2023 - ASPET
Oxycodone, a semisynthetic derivative of naturally occurring thebaine, an opioid alkaloid,
has been available for more than 100 years. Although thebaine cannot be used …

Differential patterns of synaptic plasticity in the nucleus accumbens caused by continuous and interrupted morphine exposure

EM Lefevre, EA Gauthier, LL Bystrom… - Journal of …, 2023 - Soc Neuroscience
Opioid exposure and withdrawal both cause adaptations in brain circuits that may contribute
to abuse liability. These adaptations vary in magnitude and direction following different …

Recent advances in exhaled breath sample preparation technologies for drug of abuse detection

F Xu, J Zhou, H Yang, L Chen, J Zhong, Y Peng… - TrAC Trends in …, 2022 - Elsevier
This current review focuses on contributions to exhaled breath (EB) preparation in drug of
abuse (DOA) detection. DOA has caused health hazards, accidents, criminal acts and huge …

Oxycodone, an opioid like the others?

N Marie, F Noble - Frontiers in Psychiatry, 2023 - frontiersin.org
The over-prescription of opioid analgesics is a growing problem in the field of addiction,
which has reached epidemic-like proportions in North America. Over the past decade …

Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats

JM Illenberger, FJ Flores-Ramirez, A Matzeu… - Frontiers in …, 2023 - frontiersin.org
Background: The Department of Health and Human Services reports that prescription pain
reliever (eg, oxycodone) misuse was initiated by 4,400 Americans each day in 2019. Amid …

Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders

AH Newman, ZX Xi, C Heidbreder - … Function: New Insight After 30 Years …, 2022 - Springer
Over three decades of evidence indicate that dopamine (DA) D3 receptors (D3R) are
involved in the control of drug-seeking behavior and may play an important role in the …

The respiratory depressant effects of mitragynine are limited by its conversion to 7‐OH mitragynine

R Hill, AC Kruegel, JA Javitch, JR Lane… - British Journal of …, 2022 - Wiley Online Library
Background and Purpose Mitragynine, the major alkaloid in Mitragyna speciosa (kratom), is
a partial agonist at the μ opioid receptor. CYP3A‐dependent oxidation of mitragynine yields …

Genetic addiction risk and psychological profiling analyses for “Preaddiction” severity index

K Blum, D Han, A Bowirrat, BW Downs… - Journal of Personalized …, 2022 - mdpi.com
Since 1990, when our laboratory published the association of the DRD2 Taq A1 allele and
severe alcoholism in JAMA, there has been an explosion of genetic candidate association …

Dissociable effects of oxycodone on behavior, calcium transient activity, and excitability of dorsolateral striatal neurons

J Barry, KD Oikonomou, A Peng, D Yu… - Frontiers in Neural …, 2022 - frontiersin.org
Opioids are the most common medications for moderate to severe pain. Unfortunately, they
also have addictive properties that have precipitated opioid misuse and the opioid epidemic …